This review summarizes recent advances in understanding the epidemiology, pathophysiology, and treatment of coronary artery disease in patients with hypertension.
Clinicians gain a synthesized hypertension-CAD update; leaves open optimal strategies pending prospective trials.
The commonest cause of death in patients with hypertension remains coronary artery disease, despite major therapeutic advances over the past 20 years. In view of this, there continues to be considerable interest in ways of further elucidating the relationship between these two disorders, into further understanding their pathophysiology, and towards finding effective therapy for reducing coronary mortality. This paper focuses on recent published articles furthering our knowledge of hypertension and coronary disease in the areas of epidemiology, pathophysiology, and recent therapeutic trials.
No takes yet. Share an insight, caveat, or question.
Tean et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: